Alere drags Abbott to court over $5.8 bln deal

Aug 26 (Reuters) - Alere Inc, which has agreed to be bought by Abbott Laboratories, said on Friday it filed a complaint, seeking to compel Abbott to obtain all antitrust approvals required to complete the deal.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.